Here, we again hypothesised increased LAMP2 protein abundance in grade III meningioma may arise from the plasma, a theory partially supported by Gabriele et al. (2018), who detected a significant increase in LAMP2 protein in prostate cancer patients’ sera compared to control using glycopeptide enrichment and targeted LC-MS/MS [67]. Here, LAMP2 is linked to prostate carcinoma.